← FDA Drug Approvals (Drugs@FDA)

POMALIDOMIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2022-01-26

Drug application

FDA Application #

ANDA210275

Application type

Abbreviated New Drug Application (Generic)

Brand name

POMALIDOMIDE

Generic name

Pomalidomide

Active ingredients

POMALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Discontinued

Sponsor

MYLAN

First approval

2022-01-26

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown